Genomic landscape and clonal evolution of acute myeloid leukemia with t (8; 21): an international study on 331 patients
Acute myeloid leukemia with t (8; 21)(q22; q22) is characterized by considerable clinical and
biological heterogeneity leading to relapse in up to 40% of patients. We sequenced coding …
biological heterogeneity leading to relapse in up to 40% of patients. We sequenced coding …
Genomic landscape and clonal evolution of acute myeloid leukemia with t (8; 21): an international study on 331 patients
F Christen, K Hoyer, K Yoshida, HA Hou… - …, 2019 - pubmed.ncbi.nlm.nih.gov
Acute myeloid leukemia with t (8; 21)(q22; q22) is characterized by considerable clinical and
biological heterogeneity leading to relapse in up to 40% of patients. We sequenced coding …
biological heterogeneity leading to relapse in up to 40% of patients. We sequenced coding …
Genomic landscape and clonal evolution of acute myeloid leukemia with t (8; 21)
F Christen, K Hoyer, K Yoshida, HA Hou, N Waldhueter… - Blood, 2019 - repub.eur.nl
Acute myeloid leukemia with t (8; 21)(q22; q22) is characterized by considerable clinical and
biological heterogeneity leading to relapse in up to 40% of patients. We sequenced coding …
biological heterogeneity leading to relapse in up to 40% of patients. We sequenced coding …
Genomic landscape and clonal evolution of acute myeloid leukemia with t (8; 21): an international study on 331 patients
F Christen, K Hoyer, K Yoshida, HA Hou, N Waldhueter… - Blood, 2019 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Acute myeloid leukemia with t (8; 21)(q22; q22)
is characterized by considerable clinical and biological heterogeneity leading to relapse in …
is characterized by considerable clinical and biological heterogeneity leading to relapse in …
Genomic landscape and clonal evolution of acute myeloid leukemia with t (8; 21): an international study on 331 patients.
F Christen, K Hoyer, K Yoshida, HA Hou, N Waldhueter… - Blood, 2019 - europepmc.org
Acute myeloid leukemia with t (8; 21)(q22; q22) is characterized by considerable clinical and
biological heterogeneity leading to relapse in up to 40% of patients. We sequenced coding …
biological heterogeneity leading to relapse in up to 40% of patients. We sequenced coding …
[HTML][HTML] Genomic landscape and clonal evolution of acute myeloid leukemia with t (8; 21): an international study on 331 patients
F Christen, K Hoyer, K Yoshida, HA Hou, N Waldhueter… - Blood, 2019 - Elsevier
Acute myeloid leukemia with t (8; 21)(q22; q22) is characterized by considerable clinical and
biological heterogeneity leading to relapse in up to 40% of patients. We sequenced coding …
biological heterogeneity leading to relapse in up to 40% of patients. We sequenced coding …
[PDF][PDF] Genomic landscape and clonal evolution of acute myeloid leukemia with t (8; 21): an international study on 331 patients
F Christen, K Hoyer, K Yoshida, HA Hou, N Waldhueter… - blood, 2019 - academia.edu
Acute myeloid leukemia with t (8; 21)(q22; q22) is characterized by considerable clinical and
biological heterogeneity leading to relapse in up to 40% of patients. We sequenced coding …
biological heterogeneity leading to relapse in up to 40% of patients. We sequenced coding …
Genomic landscape and clonal evolution of acute myeloid leukemia with t (8; 21): an international study on 331 patients
F Christen, K Hoyer, K Yoshida, HA Hou, N Waldhueter… - Blood, 2019 - edoc.mdc-berlin.de
Acute myeloid leukemia with t (8; 21)(q22; q22) is characterized by considerable clinical and
biological heterogeneity leading to relapse in up to 40% of patients. We sequenced coding …
biological heterogeneity leading to relapse in up to 40% of patients. We sequenced coding …
Genomic landscape and clonal evolution of acute myeloid leukemia with t (8; 21): an international study on 331 patients
F Christen, K Hoyer, K Yoshida, HA Hou, N Waldhueter… - Blood, 2019 - discovery.ucl.ac.uk
Acute myeloid leukemia (AML) with t (8; 21)(q22; q22) is characterized by considerable
clinical and biological heterogeneity leading to relapse in up to 40%. We sequenced coding …
clinical and biological heterogeneity leading to relapse in up to 40%. We sequenced coding …
Genomic landscape and clonal evolution of acute myeloid leukemia with t (8; 21): an international study on 331 patients
F Christen, K Hoyer, K Yoshida, HA Hou, N Waldhueter… - Blood, 2019 - edoc.mdc-berlin.de
Acute myeloid leukemia with t (8; 21)(q22; q22) is characterized by considerable clinical and
biological heterogeneity leading to relapse in up to 40% of patients. We sequenced coding …
biological heterogeneity leading to relapse in up to 40% of patients. We sequenced coding …